Cover Image
市場調查報告書

核醫學的全球市場 (2016∼2020年)

Global Nuclear Medicine Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 363483
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
核醫學的全球市場 (2016∼2020年) Global Nuclear Medicine Market 2016-2020
出版日期: 2016年07月15日 內容資訊: 英文 73 Pages
簡介

所謂核醫學,是專門性醫療圖像領域之一,含SPECT (單一光子輻射斷層攝影) 和PET (陽電子斷層法) 掃描等特殊的模式,用於腫瘤、心臟病、神經症等各種疾病的檢驗、分析。只放進微量的放射性物質到體內的放射性醫藥品,也包含在核醫學的範疇中。全球核醫學市場,預計2016∼2020年以8.34%的年複合成長率成長。

本報告提供全球核醫學的相關產品與服務市場相關分析,技術概要和市場基本結構,市場規模趨勢 (今後5年的預測值),各產品、各用途、各終端用戶、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 核醫學的全球市場:各產品的市場區隔

  • 全球核醫學設備市場
  • SPECT市場
  • PET市場
  • 放射性醫藥品市場

第7章 核醫學的全球市場:各用途的市場區隔

  • 腫瘤
  • 心臟病
  • 神經症

第8章 核醫學的全球市場:各終端用戶的市場區隔

  • 診斷中心
  • 醫院
  • 研究機關

第9章 核醫學的全球市場:地區區分

  • 南北美洲市場
  • 對美國的放射性醫藥品的醫療費償付
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 亞太地區市場

第10章 核醫學的全球市場:推動因素

  • SPECT/PET影像診斷的需求大小
  • 癌症、心血管疾病 (CVD)的發病數量增加
  • 放射性醫藥品的需求增加

第11章 推動因素的影響力

第12章 核醫學的全球市場:課題

  • 隨著核醫學產品的有效期短,價格的高度隨時間變化的限制
  • 核醫學產品的不足
  • 法規上的障礙

第13章 推動因素、課題的影響力

第14章 核醫學的全球市場:趨勢

  • 核醫學開發的產業聯盟
  • 迴旋加速器的生產
  • 研究開發 (R&D) 資金的增額

第15章 供應商環境

  • 競爭方案

第16章 主要供應商分析

  • Cardinal Health
  • Digirad
  • GE Healthcare
  • Lantheus Medical Imaging
  • Philips Healthcare
  • 其他卓越供應商

第17章 附錄

  • 簡稱集

第18章 關於Technavio

目錄
Product Code: IRTNTR9188

About Nuclear Medicine

Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.

Technavio's analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2016-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nuclear Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Cardinal Health
  • Digirad
  • GE Healthcare
  • Lantheus Medical Imaging
  • Philips Healthcare

Other Prominent Vendors

  • ABT Molecular Imaging
  • Advanced Accelerator Applications
  • AGFA Healthcare
  • Algeta
  • Astellas Pharma
  • Bayer
  • Bracco Imaging
  • Brain Biosciences
  • Capintec
  • CMR Naviscan
  • Cubresa
  • Eczacibasi-Monrol Nuclear Products
  • FUJIFILM Holdings
  • IBA Molecular Imaging
  • ISOLOGIC Innovative Radiopharmaceuticals
  • Jubilant DraxImage
  • Mallinckrodt
  • Mediso Medical Imaging System
  • Mirada Medical
  • Navidea Biopharmaceuticals
  • Nordion
  • Piramal Imaging
  • Positron Pharmaceutical Company
  • RadioMedix
  • SHINE Medical Technologies
  • Sophie Biosciences
  • Toshiba Medical Systems
  • Triad Isotopes
  • Voxel

Market driver

  • Growing demand for radiopharmaceuticals
  • For a full, detailed list, view our report

Market challenge

  • High cost of nuclear medicine and time constraints owing to its short half-life
  • For a full, detailed list, view our report

Market trend

  • Partnerships for development of nuclear medicine
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global nuclear medicine equipment market
  • Global SPECT market
  • Global PET market
  • Global radiopharmaceuticals market

PART 07: Market segmentation by application

  • Oncology
  • Cardiology
  • Neurology

PART 08: Market segmentation by end-user

  • Diagnostic centers
  • Hospitals
  • Research centers

PART 09: Geographical segmentation

  • Global nuclear medicine market in Americas
  • Reimbursement of radiopharmaceuticals in US
  • Global nuclear medicine market in EMEA
  • Global nuclear medicine market in APAC

PART 10: Market drivers

  • High demand for SPECT and PET imaging
  • Rising incidence of cancer and CVDs
  • Growing demand for radiopharmaceuticals

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost of nuclear medicine and time constraints owing to its short half-life
  • Shortage of nuclear medicine
  • Regulatory hurdles

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Partnerships for development of nuclear medicine
  • Production based on cyclotron
  • Growing funding for R&D

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Key vendors

  • Cardinal Health
  • Digirad
  • GE Healthcare
  • Lantheus Medical Imaging
  • Philips Healthcare
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Radioisotopes used in medical imaging
  • Exhibit 03: Global nuclear medicine market 2015-2020 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global nuclear medicine market segmentation by product
  • Exhibit 06: Global nuclear medicine market segmentation by product 2015
  • Exhibit 07: Global nuclear medicine market segmentation by product 2020
  • Exhibit 08: Global nuclear medicine equipment market 2015-2020 ($ billions)
  • Exhibit 09: Global SPECT market 2015-2020 ($ billions)
  • Exhibit 10: Global PET market 2015-2020 ($ millions)
  • Exhibit 11: Global radiopharmaceuticals market 2015-2020 ($ billions)
  • Exhibit 12: Global nuclear medicine market segmentation by application 2015
  • Exhibit 13: Global nuclear medicine market segmentation by end-user 2015
  • Exhibit 14: Global nuclear medicine market segmentation by geography 2015
  • Exhibit 15: Global nuclear medicine market segmentation by geography 2020
  • Exhibit 16: Global nuclear medicine market segmentation by geography 2015-2020
  • Exhibit 17: Global nuclear medicine market segmentation by geography 2015-2020 ($ billions)
  • Exhibit 18: Conditions diagnosed using nuclear medicine (in the US)
  • Exhibit 19: Nuclear medicine market in Americas 2015-2020 ($ billions)
  • Exhibit 20: Components for Medicare reimbursement
  • Exhibit 21: Difference in Medicare based on hospital facility and physician's offices
  • Exhibit 22: Reimbursement provided by Medicare for various nuclear medicines 2015
  • Exhibit 23: Nuclear medicine market in EMEA 2015-2020 ($ billions)
  • Exhibit 24: Nuclear medicine market in APAC 2015-2020 ($ millions)
  • Exhibit 25: Impact of drivers
  • Exhibit 26: Impact of drivers and challenges
  • Exhibit 27: Cardinal Health: Product portfolio
  • Exhibit 28: Cardinal Health: Key takeaways
  • Exhibit 29: Digirad: Business segmentation by revenue 2015
  • Exhibit 30: Digirad: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 31: Digirad: Key takeaways
  • Exhibit 32: GE Healthcare: Product portfolio
  • Exhibit 33: GE Healthcare: Key takeaways
  • Exhibit 34: Lantheus Medical Imaging: Product portfolio
  • Exhibit 35: Regulatory product approvals
  • Exhibit 36: Lantheus Medical Imaging: Product segmentation by revenue 2015
  • Exhibit 37: Lantheus Medical Imaging: Product segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 38: Lantheus Medical Imaging: Key takeaways
  • Exhibit 39: Philips Healthcare: Product portfolio
  • Exhibit 40: Philips Healthcare: Key takeaways
  • Exhibit 41: Other prominent vendors
Back to Top